The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and early efficacy results from a phase 1, multicenter trial of PSMA-targeted armored CAR T cells in patients with advanced mCRPC.
 
Meredith McKean
Consulting or Advisory Role - Array BioPharma (Inst); AstraZeneca (Inst); Pfizer (Inst); Regeneron (Inst)
Research Funding - Ascentage Pharma Group (Inst); Bicycle Therapeutics (Inst); Dragonfly Therapeutics (Inst); Epizyme (Inst); Exelixis (Inst); Genentech (Inst); GlaxoSmithKline (Inst); IDEAYA Biosciences (Inst); Ikena Oncology (Inst); Infinity Pharmaceuticals (Inst); Jacobio (Inst); Moderna Therapeutics (Inst); NBE Therapeutics (Inst); Novartis (Inst); Oncorus (Inst); Plexxikon (Inst); Prelude Therapeutics (Inst); Regeneron (Inst); Sapience Therapeutics (Inst); Seagen (Inst); Tizona Therapeutics, Inc. (Inst); Tmunity Therapeutics, Inc. (Inst); Top Alliance BioScience (Inst)
 
Matthew H. Carabasi
Employment - Merck (I)
Stock and Other Ownership Interests - Mercer (I)
Travel, Accommodations, Expenses - Merck (I)
 
Mark N. Stein
Consulting or Advisory Role - Exelixis; Exelixis; Janssen Oncology; Merck Sharp & Dohme; Oxford Oncology; Xencor
Research Funding - Advaxis (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genocea Biosciences (Inst); Harpoon (Inst); Janssen Oncology (Inst); Lilly (Inst); Medivation/Astellas (Inst); Merck Sharp & Dohme (Inst); Nektar (Inst); Oncoceutics (Inst); Seagen (Inst); Suzhou Kintor Pharmaceuticals (Inst); Tmunity Therapeutics, Inc. (Inst); Xencor (Inst)
 
Michael Thomas Schweizer
Consulting or Advisory Role - AstraZeneca; PharmaIn; Resverlogix
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); ElevateBio (Inst); Immunomedics (Inst); Immunomedics (Inst); Janssen (Inst); Madison Vaccines, Inc. (Inst); Merck (Inst); Pfizer (Inst); Roche (Inst); Tmunity Therapeutics, Inc. (Inst); Zenith Epigenetics (Inst)
 
Jason J. Luke
Stock and Other Ownership Interests - Actym Therapeutics; Alphamab; Arch Oncology; Kanaph Therapeutics; Mavu Pharmaceutical; Onc.AI; Pyxis; Tempest Therapeutics
Consulting or Advisory Role - 7 Hills Pharma; Abbvie; Alnylam; Alphamab; Astellas Pharma; Bayer; Bristol-Myers Squibb; Checkmate Pharmaceuticals; Crown Bioscience; CStone Pharmaceuticals; Eisai; EMD Serono; Flame Biosciences; Genentech; Immunocore; Immunocore; Incyte; Inzen Therapeutics; Janssen; Kadmon; KSQ Therapeutics; Merck; Mersana; Nektar; Novartis; Partner Therapeutics; Pfizer; Reflexion Medical; Regeneron; Ribon Therapeutics; Rubius Therapeutics; Silicon Therapeutics; Spring Bank; Synlogic; Tempest Therapeutics; Tesaro; TRex Bio; Werewolf Therapeutics; Xencor; Xilio Therapeutics
Research Funding - Abbvie (Inst); Agios; Array BioPharma; Astellas Pharma; BioNTech; Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); EMD Serono; Fstar; Genmab; Ikena Oncology; Immatics; Incyte (Inst); Kadmon; KAHR Medical; Macrogenics (Inst); Merck (Inst); Moderna Therapeutics; Nektar; Numab; Replimune; Rubius Therapeutics; Scholar Rock; Spring bank; Synlogic; Takeda; Tizona Therapeutics, Inc.; Trishula Therapeutics; Trishula Therapeutics; Xencor (Inst)
Patents, Royalties, Other Intellectual Property - Serial #15/612,657 (Cancer Immunotherapy),; Serial #PCT/US18/36052 (Microbiome Biomarkers for Anti-PD-1/PD-L1 Responsiveness: Diagnostic, Prognostic and Therapeutic Uses Thereof)
Travel, Accommodations, Expenses - Array BioPharma; Bristol-Myers Squibb; EMD Serono; Janssen; Merck; Mersana; Novartis; Pyxis; Reflexion Medical; Xilio Therapeutics
 
Vivek Narayan
Honoraria - Pfizer
Consulting or Advisory Role - Amgen; AstraZeneca; Exelixis; Janssen Oncology; Merck; Myovant Sciences; Pfizer/EMD Serono; Regeneron
Research Funding - Bristol-Myers Squibb (Inst); Janssen (Inst); Merck (Inst); Pfizer (Inst); Tmunity Therapeutics, Inc. (Inst)
Travel, Accommodations, Expenses - Exelixis
 
Rahul Atul Parikh
Stock and Other Ownership Interests - Myovant Sciences (I)
Consulting or Advisory Role - Merck
Research Funding - Saladax Biomedical; Taiho Pharmaceutical
Patents, Royalties, Other Intellectual Property - Patents on DNA repair pathways in cancer. I do not receive any royalties for the same.
 
Russell Kent Pachynski
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Dendreon; EMD Serono; Genomic Health; Jounce Therapeutics; Pfizer/EMD Serono; Sanofi
Speakers' Bureau - AstraZeneca; Dendreon; Genentech/Roche; Genomic Health; Merck; Sanofi
Research Funding - Janssen Oncology; Pharmacyclics (Inst)
Patents, Royalties, Other Intellectual Property - Entitled: METHOD OF CELL-FREE DNA ANALYSIS TO IDENTIFY HIGH-RISK METASTATIC PROSTATE CANCER
Travel, Accommodations, Expenses - Genentech/Roche
 
Jingsong Zhang
Honoraria - AstraZeneca/MedImmune; Bayer; Clovis Oncology; Merck; Sanofi; Seagen
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer; Clovis oncology; Dendreon; Janssen Oncology; Myovant Sciences; Seagen
Speakers' Bureau - AstraZeneca; Merck Sharp & Dohme; Sanofi; Seagen; Seagen
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - Bayer
 
Vijay Gopal Reddy Peddareddigari
Employment - Tmunity Therapeutics, Inc.
Stock and Other Ownership Interests - Autolus; Tmunity Therapeutics, Inc.
Research Funding - Tmunity Therapeutics, Inc.
Patents, Royalties, Other Intellectual Property - Hold Patents with Autolus and Tmunity therapeutics, will not receive any royalties
Travel, Accommodations, Expenses - Autolus; Tmunity Therapeutics, Inc.
 
James Winnberg
Employment - GlaxoSmithKline; Tmunity Therapeutics, Inc.
Stock and Other Ownership Interests - GlaxoSmithKline
 
Amy Roberts
Employment - Tmunity Therapeutics, Inc.
 
Jamie Rosen
Employment - Tmunity Therapeutics, Inc.
 
Pam Hufner
Employment - Tmunity Therapeutics, Inc.
Stock and Other Ownership Interests - REGENXBIO
 
Whitney Gladney
Employment - Tmunity Therapeutics, Inc.
Stock and Other Ownership Interests - Tmunity Therapeutics, Inc.
Consulting or Advisory Role - Carisma Therapeutics; Tmunity Therapeutics, Inc.
 
Thomas J. Fountaine
Employment - Tmunity Therapeutics, Inc.
 
Karen Chagin
Employment - Adaptimmune; Tmunity Therapeutics, Inc.
Stock and Other Ownership Interests - Adaptimmune; Tmunity Therapeutics, Inc.
Travel, Accommodations, Expenses - Adaptimmune